$FORL
Four Leaf Acquisition Corp

2023 Q4 Form 10-K Financial Statement

#000119312524083637 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $462.0K $1.083M $10.00K
YoY Change 10732.5%
Operating Profit -$1.083M
YoY Change
Interest Expense $762.3K $2.362M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $300.3K $1.279M -$10.00K
YoY Change -12887.8%
Income Tax $154.1K $444.0K $0.00
% Of Pretax Income 51.33% 34.72%
Net Earnings $146.2K $834.8K -$10.00K
YoY Change -8447.9%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.01 $0.12 $0.00
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.62K $10.62K $0.00
YoY Change
Cash & Equivalents $10.62K
Short-Term Investments
Other Short-Term Assets $49.84K $49.84K $10.00K
YoY Change 398.4% 398.4%
Inventory
Prepaid Expenses $49.84K
Receivables
Other Receivables
Total Short-Term Assets $60.46K $60.46K $10.00K
YoY Change 421.21% 504.6%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $58.06M $58.06M
YoY Change
Other Assets $0.00 $0.00 $710.0K
YoY Change -100.0% -100.0%
Total Long-Term Assets $58.06M $58.06M $710.0K
YoY Change 8134.47% 8077.99%
TOTAL ASSETS
Total Short-Term Assets $60.46K $60.46K $10.00K
Total Long-Term Assets $58.06M $58.06M $710.0K
Total Assets $58.12M $58.12M $720.0K
YoY Change 8009.64% 7972.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $402.7K $402.7K
YoY Change
Accrued Expenses $97.44K $97.44K $390.0K
YoY Change -75.02% -75.02%
Deferred Revenue
YoY Change
Short-Term Debt $272.0K $272.0K $310.0K
YoY Change -12.26% -12.26%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.470M $1.470M $700.0K
YoY Change 110.52% 109.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.897M $1.897M
YoY Change
Total Long-Term Liabilities $1.897M $1.897M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.470M $1.470M $700.0K
Total Long-Term Liabilities $1.897M $1.897M $0.00
Total Liabilities $3.367M $3.367M $700.0K
YoY Change 382.33% 380.98%
SHAREHOLDERS EQUITY
Retained Earnings -$1.310M
YoY Change 20677.56%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $54.76M $54.76M $20.00K
YoY Change
Total Liabilities & Shareholders Equity $58.12M $58.12M $720.0K
YoY Change 8009.64% 7972.81%

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income $146.2K $834.8K -$10.00K
YoY Change -8447.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$170.9K -$466.7K -$10.00K
YoY Change -1809.3% 4566.7%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$55.84M $0.00
YoY Change
Cash From Investing Activities $0.00 -$55.84M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $57.79M $30.00K
YoY Change 192523.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 177.0K 56.31M 20.00K
YoY Change 281461.6%
NET CHANGE
Cash From Operating Activities -170.9K -466.7K -10.00K
Cash From Investing Activities 0.000 -55.84M 0.000
Cash From Financing Activities 177.0K 56.31M 20.00K
Net Change In Cash 6.070K 9.350K 10.00K
YoY Change -39.3% -6.5%
FREE CASH FLOW
Cash From Operating Activities -$170.9K -$466.7K -$10.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001936255
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
Four Leaf Acquisition Corporation
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity File Number
EntityFileNumber
001-41646
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1178935
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
4546 El Camino Real B10 #715
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Altos
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94022
CY2023 dei City Area Code
CityAreaCode
650
CY2023 dei Local Phone Number
LocalPhoneNumber
720-5626
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
56504167
CY2023 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.fourleaf.com/20231231#ChangeInFairValueOfOverallotmentOptionLiability
CY2022 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.fourleaf.com/20231231#ChangeInFairValueOfOverallotmentOptionLiability
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
Costa Mesa, CA
CY2023Q4 us-gaap Cash
Cash
10622
CY2022Q4 us-gaap Cash
Cash
1280
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
49842
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7500
CY2023Q4 us-gaap Assets Current
AssetsCurrent
60464
CY2022Q4 us-gaap Assets Current
AssetsCurrent
11600
CY2023Q4 forlu Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
58063737
CY2022Q4 forlu Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
0
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
0
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
705130
CY2023Q4 us-gaap Assets
Assets
58124201
CY2022Q4 us-gaap Assets
Assets
716730
CY2023Q4 forlu Accruedofferingcostscurrent
Accruedofferingcostscurrent
97440
CY2022Q4 forlu Accruedofferingcostscurrent
Accruedofferingcostscurrent
386536
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
402663
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
0
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62180
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2023Q4 forlu Convertible Note Related Party Current
ConvertibleNoteRelatedPartyCurrent
272000
CY2022Q4 forlu Convertible Note Related Party Current
ConvertibleNoteRelatedPartyCurrent
0
CY2023Q4 forlu Deferred Credit Insurance Fee Current
DeferredCreditInsuranceFeeCurrent
191250
CY2022Q4 forlu Deferred Credit Insurance Fee Current
DeferredCreditInsuranceFeeCurrent
0
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
443990
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1469523
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
698036
CY2023Q4 forlu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
1897350
CY2022Q4 forlu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
0
CY2023Q4 us-gaap Liabilities
Liabilities
3366873
CY2022Q4 us-gaap Liabilities
Liabilities
698036
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
56067420
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24850
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1310233
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6306
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1310092
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18694
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58124201
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
716730
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1083245
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6306
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1083245
us-gaap Operating Income Loss
OperatingIncomeLoss
-6306
CY2023 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2227437
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-134583
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1278775
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6306
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
443990
CY2023 us-gaap Net Income Loss
NetIncomeLoss
834785
us-gaap Net Income Loss
NetIncomeLoss
-6306
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18694
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
270520
CY2023 forlu Accretion Of Class A Ordinary Shares To Accreted Value
AccretionOfClassAOrdinarySharesToAccretedValue
-7138931
CY2023 us-gaap Net Income Loss
NetIncomeLoss
834785
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1310092
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Net Income Loss
NetIncomeLoss
-6306
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18694
CY2023 us-gaap Net Income Loss
NetIncomeLoss
834785
us-gaap Net Income Loss
NetIncomeLoss
-6306
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2227437
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
0
CY2023 forlu Change In Fair Value Of Overallotment Option Liability
ChangeInFairValueOfOverallotmentOptionLiability
-134583
forlu Change In Fair Value Of Overallotment Option Liability
ChangeInFairValueOfOverallotmentOptionLiability
0
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-45314
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7500
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
506257
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0
CY2023 forlu Increase Decrease In Due To Or From Related Party
IncreaseDecreaseInDueToOrFromRelatedParty
-65000
forlu Increase Decrease In Due To Or From Related Party
IncreaseDecreaseInDueToOrFromRelatedParty
2820
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
443990
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-466674
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16626
CY2023 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
55836300
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55836300
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
272000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
84000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
311500
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
318594
CY2023 forlu Proceeds From Issuance Of Common Stocks
ProceedsFromIssuanceOfCommonStocks
0
forlu Proceeds From Issuance Of Common Stocks
ProceedsFromIssuanceOfCommonStocks
25000
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
395500
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54210000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2023 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3577000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
CY2023 forlu Payment Of Offering Costs On Public Units
PaymentOfOfferingCostsOnPublicUnits
1435184
forlu Payment Of Offering Costs On Public Units
PaymentOfOfferingCostsOnPublicUnits
0
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56312316
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17906
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9342
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1280
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1280
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10622
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1280
CY2023 forlu Remeasurement Of Class A Shares Subject To Possible Redemption
RemeasurementOfClassASharesSubjectToPossibleRedemption
7138931
forlu Remeasurement Of Class A Shares Subject To Possible Redemption
RemeasurementOfClassASharesSubjectToPossibleRedemption
0
CY2023 forlu Deferred Underwriting Commissions.
DeferredUnderwritingCommissions.
1897350
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 forlu Effective Income Tax Rate Change In Fair Value Of Overallotment Liability
EffectiveIncomeTaxRateChangeInFairValueOfOverallotmentLiability
-2.21
forlu Deferred Underwriting Commissions.
DeferredUnderwritingCommissions.
0
CY2023 us-gaap Stock Issued1
StockIssued1
270520
us-gaap Stock Issued1
StockIssued1
0
CY2023 forlu Directors And Officers Insurance Fee Paid By Potential Target
DirectorsAndOfficersInsuranceFeePaidByPotentialTarget
191250
forlu Directors And Officers Insurance Fee Paid By Potential Target
DirectorsAndOfficersInsuranceFeePaidByPotentialTarget
0
CY2023 forlu Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
97440
forlu Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
386536
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54210000
CY2023Q1 forlu Transaction Costs
TransactionCosts
4019087
CY2023Q1 forlu Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
2710500
CY2023Q1 forlu Payment Of Deferred Underwriting Fees
PaymentOfDeferredUnderwritingFees
813150
CY2023Q1 forlu Other Offering Costs
OtherOfferingCosts
1038067
CY2023Q1 us-gaap Cash
Cash
974028
CY2023Q1 forlu Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2023Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2023Q4 forlu Percentage Of Shares Sold In Ipo That Can Be Transferred Without Any Restriction
PercentageOfSharesSoldInIpoThatCanBeTransferredWithoutAnyRestriction
0.15
CY2023Q4 forlu Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination
PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
1
CY2023 forlu Combination Period
CombinationPeriod
P12M
CY2023 forlu Per Unit Value Of Restricted Assets Per Extension
PerUnitValueOfRestrictedAssetsPerExtension
0.1
CY2023Q4 forlu Per Unit Value Of Restricted Assets
PerUnitValueOfRestrictedAssets
0.2
CY2023 forlu Extended Business Combination Period
ExtendedBusinessCombinationPeriod
P18M
CY2023Q4 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2023Q4 forlu Amount Per Share To Be Maintained In The Trust Account
AmountPerShareToBeMaintainedInTheTrustAccount
10.3
CY2023Q4 us-gaap Cash
Cash
10622
CY2023Q4 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2023 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0
CY2023Q4 us-gaap Cash
Cash
10622
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Significant assumptions include the fair value of the Company’s Public Warrants and Representative Shares, at their issuance dates, and the valuation of the over-allotment option provided to the underwriters. Actual results could differ from those estimates. </div>
CY2022 forlu Effective Income Tax Rate Change In Fair Value Of Overallotment Liability
EffectiveIncomeTaxRateChangeInFairValueOfOverallotmentLiability
0
CY2023 forlu Proceeds From Trust Account To Pay Tax Obligations
ProceedsFromTrustAccountToPayTaxObligations
0
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of its cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. </div>
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.1593
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3472
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q2 forlu Recovered From Unauthorized Payee
RecoveredFromUnauthorizedPayee
54300
CY2023Q2 forlu Paid To Unauthorized Payee Monetary
PaidToUnauthorizedPayeeMonetary
54300
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 forlu Percentage Of Common Stock On Conversion Of Shares
PercentageOfCommonStockOnConversionOfShares
0.20
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2023Q4 us-gaap Share Price
SharePrice
0.81
CY2023Q4 forlu Aggregate Grant Date Fair Value Of The Awards
AggregateGrantDateFairValueOfTheAwards
40500
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
40500
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
443990
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
443990
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
203709
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1324
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
203709
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1324
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
443990
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q4 forlu Deferred Tax Asset Startup Expenses
DeferredTaxAssetStartupExpenses
205034
CY2022Q4 forlu Deferred Tax Asset Startup Expenses
DeferredTaxAssetStartupExpenses
1324
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
205034
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1324
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
205034
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1324
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0

Files In Submission

Name View Source Status
0001193125-24-083637-index-headers.html Edgar Link pending
0001193125-24-083637-index.html Edgar Link pending
0001193125-24-083637.txt Edgar Link pending
0001193125-24-083637-xbrl.zip Edgar Link pending
d745148d10k.htm Edgar Link pending
d745148dex311.htm Edgar Link pending
d745148dex312.htm Edgar Link pending
d745148dex321.htm Edgar Link pending
d745148dex322.htm Edgar Link pending
d745148dex46.htm Edgar Link pending
d745148dex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
forlu-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
forlu-20231231_cal.xml Edgar Link unprocessable
forlu-20231231_def.xml Edgar Link unprocessable
forlu-20231231_lab.xml Edgar Link unprocessable
forlu-20231231_pre.xml Edgar Link unprocessable
d745148d10k_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable